SanTan Medical Launches Navolution Series Orthopedic Surgical Navigation and Positioning System – Highlights Core Technological Breakthroughs and Clinical Achievements

With the deep integration of artificial intelligence and precision medicine technologies,Global Orthopedic Surgical RobotsThe market continues to experience rapid growth. According to forecasts by authoritative institutions, the market size will exceed $12.5 billion in 2025, with a compound annual growth rate (CAGR) of 18.3%. In China, the dual drivers of an accelerating aging process (with over 280 million people aged 60 and above) and a rising incidence of orthopedic diseases (adding 5 million new patients annually) are creating a multi-billion-dollar market opportunity for domestically produced enterprises, given that the current penetration rate of surgical robots remains below 1%.

Hangzhou Santan Medical Technology Co., Ltd. (hereinafter referred to as “Santan Medical”), founded in 2010, specializes in the niche field of orthopedic surgical robots. It is a leading enterprise in the surgical robot sector, established by renowned clinical experts, and currentlyCertified as a National High-Tech Enterprise, Provincial Specialized and Sophisticated Enterprise, “Bai Ge” Enterprise, and Phoenix Plan “New Seedling” Enterprise.Leveraging the strong national policy support for the artificial intelligence industry, Santan Medical andUnitree Robotics, DeepSeekWaitArtificial Intelligence EnterprisesForging new momentum for the development of Hangzhou’s artificial intelligence sector.

Santan Medical focuses onClinical Efficacy,and has collaborated with multiple leading domestic medical institutions to establish a clinical platform integrating medicine and engineering. The product portfolio supports surgical procedures in orthopedic trauma, spine, and joints, with current clinical applications of the productsOver 20,000 cases,Covered Surgical ProceduresOver 70 types,The product’s strength has garnered widespread acclaim. After 14 years,Santan Medical has achieved original breakthroughs in core technologies such as laser navigation, multimodal image registration, hybrid force-position control, and AI-based surgical planning. The company holds four innovative Class II/III medical device registration certificates and has filed over 300 patents and software copyrights, demonstrating industry-leading R&D capabilities.Currently, Santan Medical has established"Government Certification - R&D Strength - Innovation Achievements" Trinityscientific research qualification system, the company has been honored with multiple qualifications including National High-Tech Enterprise, Provincial Specialized and Sophisticated “Little Giant” Enterprise, and Provincial R&D Center, and is undertaking multiple ongoing research projects.

On Monday, April 28, at 19:30, the 131st edition of VCBeat New Product Review will feature Liu Dapeng, Director of the Department of Comprehensive Orthopedics at the People’s Hospital of Xinjiang Uygur Autonomous Region; Xu Ziang, General Manager of Hangzhou Santan Medical Technology Co., Ltd.; and Zhuo Jianjiang, Sales Director of Hangzhou Santan Medical Technology Co., Ltd., who will present“Orthopedic Surgical Navigation and Positioning System (Navolution Series)”Breakthroughs in Core Product Technologies and Clinical Application Achievements: In-Depth Analysis of Industry Trends, Product Advantages, and Collaboration Opportunities.

Orthopedic Surgical Navigation and Positioning System (Navolution Series)

Scan the QR code on the poster to add our assistant and reserve a spot for the live broadcast.

Liu Dapeng

Director of the Department of General Orthopedics, Orthopedic Center; Chief Physician

Ph.D. and Master's Supervisor

He has undertaken advanced training at the Department of Spinal Surgery, University Hospital Center of Besançon, France; the Bone and Soft Tissue Tumor Center, Peking University People’s Hospital; the Department of Orthopedic Surgery, Beijing Jishuitan Hospital; and the Department of Traumatic Orthopedics, Shanghai Sixth People’s Hospital. With 30 years of experience in clinical practice, scientific research, and teaching in orthopedics, he has been dedicated to the application, research and development, and promotion of digital orthopedic technologies since 2009.

In March 2013, he took the lead in establishing the Digital Orthopedics Laboratory in Xinjiang and hosted the first Digital Orthopedics Training Course in the region. Subsequently, he led his team in leveraging digital technologies and 3D printing to develop novel techniques, including osteotomy guide plates for limb deformities, pedicle screw guide plates for the spine, knee arthroplasty guide plates, and patient-specific 3D-printed acetabular revision prostheses. These technologies were among the first in China to be applied in clinical surgeries, enabling the successful performance of complex high-difficulty procedures such as multi-planar deformity-correcting knee arthroplasty, decompression for severe cervical spinal canal ossification of the posterior longitudinal ligament, cervical pedicle screw fixation, hip revision surgery for massive acetabular bone defects, and total hip arthroplasty for Crowe type IV developmental dysplasia of the hip. His work has been featured multiple times by media outlets including Xinjiang City Daily, Xinjiang Morning Post, Xinjiang Television, and Tianshan Net.

Since 2022, we have pioneered robotic-assisted orthopedic surgeries in Xinjiang, including channel screw fixation for pelvic fractures, percutaneous kyphoplasty (PKP) for spinal compression fractures, minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) for lumbar spondylolisthesis, and high tibial osteotomy (HTO) for knee osteoarthritis. These procedures have achieved the benefits of minimal incisions, reduced pain, and accelerated recovery.

Since 2013, four sessions of Clinical Anatomy Workshops and six sessions of Workshops on New Advances in Digital Orthopedics have been held, providing instruction to more than 300 participants from within and outside Xinjiang. These efforts have enabled a broad patient population to benefit from the technological achievements of “medical-engineering integration and precision medicine.”

Xu Zi'ang

General Manager, Hangzhou Santan Medical Technology Co., Ltd.

Master of Science in Digital Orthopedics, with over a decade of in-depth experience in the surgical robotics industry. Has comprehensively engaged across all sectors of industry, academia, research, and clinical practice. Participated in the drafting of clinical guidelines and diagnostic and treatment protocols for orthopedic robotic surgery, as well as the formulation of industry standards for medical surgical robots. Organized multiple Good Clinical Practice (GCP) clinical trials, including one that facilitated regulatory approval for an innovative Class III medical device. As the primary inventor, has secured more than 10 Chinese national invention patents and 2 PCT patents.

Zhuo Jianjiang

Deputy General Manager of Hangzhou Santan Medical Technology Co., Ltd.

Zhejiang University EMBA, with deep expertise in the medical sales sector. Possesses exceptional market insight and resource integration capabilities, with extensive experience in distributor expansion and client acquisition. Adept at building a vertical management system for the national healthcare market, and is a senior expert in the field of medical device sales.

Hangzhou Santan Medical Technology Co., Ltd. was founded in 2011 and is a national high-tech enterprise led by domestic medical experts, specializing in orthopedic surgical robots.

The company’s product R&D focuses on clinical efficacy. In collaboration with multiple leading medical institutions in China, it has established a clinical platform integrating medicine and engineering. Its product portfolio supports surgical procedures in orthopedic trauma, spine, and joint specialties. To date, the products have been utilized in over 20,000 surgeries, covering more than 70 surgical techniques, and have received widespread acclaim for their performance.

Over the past 14 years, the company has achieved original breakthroughs in core technologies such as laser navigation, image registration, robotic arm control, and AI. Currently, the company holds four registration certificates for Class II and Class III innovative medical devices, has filed more than 300 domestic and international patents and software copyrights, and boasts industry-leading comprehensive R&D capabilities.

“Artery New Product Showcase” is a live-streaming series dedicated to supporting the launch of innovative products by healthcare companies. The program’s mission is to empower every milestone launch of innovative medical products. If your company has plans to release an innovative medical product or achieve a significant milestone and wishes to participate in the “Artery New Product Showcase,” please add our assistant for inquiries.

Scan the QR code below to contact the assistant and schedule a live broadcast (if you have already added them, please reach out to the assistant directly).

Scan the QR code below to download the VCBeat app and register to watch the live stream.

Send a screenshot of the live stream to the assistant to enter the lucky draw for a chance to win a [15-day trial membership to VBInsight Industry Think Tank]